Propranolol: Difference between revisions

(Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template))
(Switch SMW query from broadtable to table format for better layout with TOC)
 
(One intermediate revision by the same user not shown)
Line 63: Line 63:
  |?Has Route=Route
  |?Has Route=Route
  |?Has Population=Population
  |?Has Population=Population
  |format=broadtable
  |format=table
  |headers=plain
  |headers=plain
  |link=subject
  |mainlabel=-
  |sort=Has Indication
  |sort=Has Indication
  |limit=50
  |limit=50

Latest revision as of 21:56, 20 March 2026

General

  • Type: Beta blockers, nonselective
  • Dosage Forms:
    • IV: 1mg/mL
    • PO conventional: 10, 20, 40, 60, 80mg
    • PO extended release: 60, 80, 120, 160mg
  • Common Trade Names: Inderal

Adult Dosing

  • Thyroid storm
    • 1-2mg IV over 10 min; if tolerates then 1-2mg boluses q15 minutes until HR <100
    • May follow with drip @ dose required for HR control (ie 3-5mg/hr)
    • Alternate 60-80mg PO q4h
  • Variceal bleed ppx
    • 20mg BID titrated up to max tolerated dose
  • Migraine ppx
    • Starting dose 80mg daily as either XL or divided q6-8hr. Max 160-240mg/day
  • Essential tremor
    • 40mg BID starting dose
  • HOCM
    • 80-160mg daily as either XL or divided q6-8 hr
  • Akathisia
    • 10mg bid-tid starting dose. Max 120mg / day

Pediatric Dosing

Special Populations

  • Pregnancy Rating: Category C; risk of IUGR, neonatal hypoglycemia/bradycardia/respiratory depression. Still preferred agent for thyrotoxicosis
  • Lactation: Enters breast milk
  • Renal Dosing: N/A
  • Hepatic Dosing: N/A

Contraindications

  • Allergy to class/drug
  • Decompensated heart failure, except high output failure secondary to tachyarrhythmia
  • Bradycardia / high degree heart block

Adverse Reactions

Serious

  • Rebound symptoms with abrupt withdrawal of treatment
  • Heart failure
  • Agranulocytosis, thrombocytopenia
  • Bronchospasm
  • SJS/TEN

Common

  • Bradycardia
  • Orthostasis

Pharmacology

  • Half-life: 3-6 hrs, 8-10 hrs extended release
  • Metabolism: Hepatic
  • Excretion: Urine
  • Mechanism of Action: Nonselective β-blocker


Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.

IndicationDoseContextRoutePopulation
Congenital heart disease0.2mg/kg IVTet spell (TOF), relieves infundibular spasmIVPediatric
Electrical storm1mg IV q5min up to 0.15mg/kgSympathetic blockadeIVAdult
Thyroid storm60-80 mg PO q4h; or 1-2 mg IV over 10 min, then 1-2 mg IV q15min until HR <100, then 3-5 mg/hr dripBeta-blocker (1st line, also blocks T4→T3)PO/IVAdult

See Also

References

Lexicomp